AtaiBeckley (ATAI) Depreciation and Depletion (2024 - 2026)
AtaiBeckley's (ATAI) quarterly Depreciation and Depletion came in at $200000.0 in Q3 2025, little changed year-on-year from $200000.0 in Q3 2024, and up 100.0% quarter-over-quarter from $100000.0 in Q2 2025.
AtaiBeckley (ATAI) Depreciation and Depletion (2024 - 2026) Analysis & Trends
AtaiBeckley's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- Depreciation and Depletion for Q3 2025 came in at $200000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $500000.0 (changed N/A YoY), and the FY2024 annual result was $200000.0, up 100.0% from the prior year.
- Depreciation and Depletion came in at $200000.0 for Q3 2025 at AtaiBeckley, up from $100000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $100000.0 in Q1 2025 to a low of $100000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |